Harvard Management as of Sept. 30, 2020
Portfolio Holdings for Harvard Management
Harvard Management holds 24 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Royalty Pharma Shs Cl A (RPRX) | 34.0 | $618M | 15M | 42.07 | |
| Facebook Cl A (META) | 15.7 | $285M | 1.1M | 261.90 | |
| Alphabet Cap Stk Cl A (GOOGL) | 12.6 | $229M | 157k | 1465.60 | |
| Palo Alto Networks (PANW) | 9.8 | $178M | 726k | 244.75 | |
| Intercontinental Exchange (ICE) | 6.4 | $116M | 1.2M | 100.05 | |
| Uber Technologies (UBER) | 5.5 | $99M | 2.7M | 36.48 | |
| Scientific Games (LNW) | 5.1 | $94M | 2.7M | 34.91 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 1.7 | $32M | 113k | 277.84 | |
| Revolution Medicines (RVMD) | 1.3 | $23M | 670k | 34.80 | |
| Relay Therapeutics (RLAY) | 1.3 | $23M | 541k | 42.59 | |
| Ishares Tr Core S&p500 Etf (IVV) | 1.2 | $22M | 65k | 336.07 | |
| Spdr Gold Tr Gold Shs (GLD) | 1.2 | $21M | 119k | 177.12 | |
| Generation Bio (GBIO) | 0.9 | $16M | 506k | 30.91 | |
| Pliant Therapeutics (PLRX) | 0.7 | $13M | 562k | 22.65 | |
| Nucana Sponsored Adr (NCNA) | 0.7 | $12M | 2.3M | 5.19 | |
| Nurix Therapeutics (NRIX) | 0.6 | $11M | 315k | 34.91 | |
| Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) | 0.4 | $7.1M | 174k | 40.90 | |
| Ishares Tr Core S&p Scp Etf (IJR) | 0.2 | $3.5M | 50k | 70.23 | |
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 0.2 | $3.5M | 80k | 43.24 | |
| Ishares Tr Core S&p Mcp Etf (IJH) | 0.2 | $3.4M | 19k | 185.29 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $3.3M | 411k | 7.93 | |
| Magenta Therapeutics | 0.1 | $2.3M | 333k | 6.80 | |
| Asana Cl A (ASAN) | 0.1 | $2.2M | 76k | 28.80 | |
| Dyne Therapeutics (DYN) | 0.1 | $2.2M | 107k | 20.19 |
